Over the past year there were no insider purchases at Zepp Health Corp. Two insiders sold roughly $87,000 instead.
Keep in mind most insider selling is routine — stock-based pay has to be converted to cash at some point.
Quarter by quarter: 2 quarters in a row of net selling by insiders. Insiders bought in 0 of the last 7 full quarters. 26 investment managers listed ZEPP in their latest 13F filings (Q2 2026); funds were split between buying and selling.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Sep 25, 2026 | Yu Pengtao | Executive Officer | Sell | 4,251 | $4.09 | $17K | SEC |
| Sep 25, 2026 | Yu Pengtao | Executive Officer | Sell | 5,749 | $4.30 | $25K | SEC |
| Jun 29, 2026 | Deng Cheng | CFO | Sell | 9,836 | $4.61 | $45K | SEC |
In the last 12 months Zepp Health Corp insiders made open-market purchases worth about $0 and sales worth about $87,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in ZEPP was filed on 2026-09-25.
26 investment managers reported holding ZEPP in SEC Form 13F filings for Q2 2026.
No congressional trades in ZEPP were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).